PLUS THERAPEUTICS, INC. — Director's Dealing 2010

Feb 9, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-02-05

Reporting Person: CALHOUN CHRISTOPHER J (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-05	Employee Stock Option	$6.71	A	150000	Acquired	2020-02-05	Common Stock (150000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	131250	Direct
Common Stock	36850	Indirect

Footnotes

F1: The Employee stock options vest 1/48th each month from date of grant.